Cellectar Biosciences Inc (CLRB) Stock Price, Quote, News & History

CLRBNASDAQ
$3.18
0.3512.37%
At close: May 4, 5:00 PM EST
$2.96
0.134.59%
Pre-Market: 6:15 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-23.12M
Investing Cash Flow (TTM)
-5.88K
Financing Cash Flow (TTM)
13.03M
Free Cash Flow (TTM)
-23.12M
Capital Expenditure (TTM)
-5.88K
Net Change in Cash (TTM)
-10.09M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.30M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.69
Earnings Yield % (TTM)
-260.94%
Earnings Yield % (FWD)
-154.22%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.89

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$13.20M
Debt to Equity
0.05
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$3.18
Volume / Avg.
140.76K / 916.30K
Day Range
- - -
52 Wk Range
2.43 - 20.59
Market Cap
$12.55M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
0.64%
Days to Cover
1.25

About

Sector
Health Care
Industry
Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cellectar Biosciences (CLRB) stock?

A

You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cellectar Biosciences (CLRB) competitors?

A

There are no as such competitors for Cellectar Biosciences.

Q

What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?

A

Cellectar Biosciences has a consensus price target of $19.00.

Q

What is the current price for Cellectar Biosciences (CLRB)?

A

The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.96 last updated May 6, 2026 at 6:15 AM EDT.

Q

Does Cellectar Biosciences (CLRB) pay a dividend?

A

There are no upcoming dividends for Cellectar Biosciences.

Q

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

A

Cellectar Biosciences does not have any upcoming earnings scheduled.

Q

Is Cellectar Biosciences (CLRB) going to split?

A

There is no upcoming split for Cellectar Biosciences.

Q

What sector and industry does Cellectar Biosciences (CLRB) operate in?

A

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.